Sed board
BioSymposia engages recognized experts in the fields of neurology, oncology, structural biochemistry, organizational management, adult education and genetics as consultant advisors on its Strategic Education Direction ("SED") Advisory Board. The SED Board helps to evaluate the effectiveness of BioSymposia's continuing medical education programs, provides strategic and visionary direction regarding trends in healthcare and scientific research and periodically reviews BioSymposia's mission to ensure it remains responsive to the scientific and medical communities' needs.
 | Gregory A. Petsko, D.Phil.
Gyula & Katica Tauber Professor of Biochemistry & Molecular Pharmcodynamics at Brandeis University |
Chairman, SED Board
Petsko/Ringe Laboratory
Dr. Petsko graduated Summa Cum Laude from Princeton University in 1970, and received a Rhodes Scholarship to Oxford University, where he completed his doctoral research in 1973 under the direction of Sir David C. Phillips. After a brief postdoctoral sojourn in Paris with Prof. Pierre Douzou, he was an Instructor and Assistant Professor of Biochemistry at Wayne State University School of Medicine from 1973 through 1978, where he twice received a Faculty Research Award. At the Massachusetts Institute of Technology he served as an Associate Professor of Chemistry from 1978 through 1985 and Professor of Chemistry from 1985 through 1989. In 1990 he was appointed the Lucille P. Markey Professor in Biochemisty and Chemisty at Brandeis University. From 1994 to 2006 he served as the Director of the Rosenstiel Basic Medical Sciences Research Center, at Brandeis Unviersity; and since 1996 has held the title of Gyula and Katica Tauber Professor of Biochemistry and Molecular Pharmacodynamics.
Dr. Petsko’s research interests center upon the structural basis of biochemical properties. His work addresses diverse biochemical problems such as: the structural origins of enzyme catalytic power; the functional role of protein flexibility; the biochemistry and genetics of the quiescent state of the eukaryotic cell, using yeast as a model organism, and the causes and treatment of neurodegenerative diseases such as Alzheimer’s and Parkinson’s Disease.
Dr. Petsko is a co-founder of ArQule, Inc. of Woburn Massachusetts, one of the world’s leading companies in combinatorial chemistry, and serves on the boards of several other biotechnology companies, including Microbia and Compound Therapeutics. He is a member of both the Scientific Review Board and the Medical Advisory Board of the Howard Hughes Medical Institutes.
 |
 | David Hafler, M.D.
Professor of Neurology at Harvard Medical School |
Dr. Hafler is a clinical neurologist trained experimentally as an immunologist. He heads the Division of Molecular Immunology in the Center for Neurologic Diseases of Harvard Medical School and the Brigham and Women’s Hospital and is an Associate Member of the Broad Institute of Massachusetts Institute of Technology. Dr. Hafler’s research has characterized human immune responses to autoantigens, developed an understanding of the underlying loss of regulation of immune responses leading to human autoimmune disease, and is actively involved in identifying the genetic variation associated with human inflammatory immune responses. As a clinician actively engaged in the development of clinical trials, his laboratory is actively engaged in the translation of experimental findings to therapies for human diseases.
|
 | Cynthia Ingols, Ed.D.
Associate Professor of Management at Simmons School of Management |
Dr. Ingols is an experienced professor, consultant and researcher, who specializes in the ways individuals lead and organizations negotiate their environments. At the Simmons School of Management, she teaches in both the MBA and Executive Education programs. In the MBA program, she teaches Leading Organizational Change and Career Strategies. Dr. Ingols is the faculty director of Strategic Leadership for Women, an executive education program that strengths the leadership skills, attitudes and motivations of its participants. Earlier in her career, she taught Management Communication at the Harvard Business School and qualitative research methodology courses at other institutions.
For three decades Dr. Ingols has worked as an organization consultant. She focuses her consulting work in three areas: developing interactive executive education programs, particularly using cases; coaching managers and executives to enhance their leadership potential and careers; and conducting diagnostic work to promote change in organizations. Past clients include: The Boeing Corporation, the US Department of Defense, Harvard University, and Verizon. Recently, Ingols worked with 25 upper-middle managers at Harvard University in a five-part practicum on how to successfully lead change across the university.
|
 | Barrett J. Rollins, M.D., Ph.D.
Professor of Medicine at Harvard Medical School |
Dr. Rollins' Website
Dr. Rollins is a graduate of Amherst College, and received his M.D. and Ph.D. from Case Western Reserve University. After completing his specialty training in Internal Medicine at Beth Israel Hospital and in Medical Oncology at Dana-Farber Cancer Institute, Dr. Rollins joined the faculty at Dana-Farber where he leads a research program in the area of inflammation and cancer. Dr. Rollins is Professor of Medicine at Harvard Medical School and holds the position of Chief Scientific Officer at Dana-Farber Cancer Institute.
|
 | Judith E. Tsipis, Ph.D.
Professor of Biology at Brandeis University |
Dr. Tsipis received her undergraduate training at the University of Rochester and her graduate training at M.I.T. (Ph.D. in Biology 1971) and has been on the faculty of the Biology Department at Brandeis University since 1976. She also serves as the Director of the Master's Degree Program in Genetic Counseling at Brandeis, a program she helped found in 1992. The Brandeis Genetic Counseling Program is one of only 28 such programs in the country and was the first to start in New England.
Dr. Tsipis is also the Chair of the Board of the Justice Resource Institute, Inc., former Co-Chair of the Canavan Disease Screening Consortium, past VP for Education of National Tay Sachs and Allied Diseases Association and an active member of the National Society of Genetic Counselors.
Her involvement in the training of genetic counselors and the above organizations derives in great measure from her own experiences as the parent of a child with Canavan disease, a rare and progressive neurological genetic disorder.
|
